—
The Missouri-based Katalyst MD is now offering a groundbreaking, newly FDA-approved spinal cord stimulation therapy to offer relief to chronic pain sufferers. Katalyst currently provides a range of treatments to help patients suffering a broad spectrum of ailments.
More information about Katalyst and services offered is available at https://katalystmd.com
According to a recent study National Health Survey, approximately 20 percent of U.S. adults have chronic pain and 8 percent have high-impact chronic pain—meaning pain that limited at least one major life activity. An estimated 50 million people in the United States suffer from chronic pain and it affects more Americans than diabetes, heart disease and cancer combined.
To help treat such chronic pain sufferers, Dr. Kaylea Boutwell of Missouri-based Katalyst MD is now offering a cutting-edge and newly FDA-approved procedure that uses neurostimulation for people living with chronic pain.
Dr. Kaylea Boutwell’s patients can now receive treatment using Abbott’s proprietary BurstDR stimulation waveform – something which mimics natural patterns found in the brain. The treatment works by using low doses of mild electrical pulses to change pain signals as they travel from the spinal cord to the brain.
Of 24 enrolled patients on a low-energy BurstDR dosing program, 100% experienced pain relief with less than six hours of battery use per day, while approximately 50% of those patients achieved pain relief with the lowest effective dose.
Apart from chronic pain management using the latest medical innovations, Dr. Kaylea Boutwell also offers a host of other therapies that help manage pain and disease, sports injuries, sleep deprivation, medication dependency issues, menopause, diet and weight loss, health and skin treatments, depression and anxiety and memory loss.
In the words of Dr. Kaylea Boutwell “Through trailblazing scientific-based procedures, medication management, and lifestyle upgrades, Katalyst helps our patients reach their goals of living fulfilling lives.”
For qualified medical advice and information on the BurstDR treatment, Dr. Kaylea Boutwell can be contacted via the URL above.
Release ID: 88933851